How do I document a Stage II pressure injury with a central 0.5 cm raised nodule, pink intact periwound skin, and no systemic infection in a type 2 diabetic patient (HbA1c 7.2 %) who is ambulating with assistance and has no recent corticosteroid use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Documentation of Stage II Pressure Injury with Central Nodule

Document this wound as a Stage II pressure injury with atypical features requiring urgent evaluation for malignancy, infection, and vascular compromise—the presence of a raised central nodule in a diabetic patient mandates immediate biopsy consideration because lesions appearing as diabetic foot ulcers may occasionally be malignancies such as melanoma or Kaposi sarcoma. 1

Immediate Documentation Requirements

Wound Classification and Baseline Measurements

  • Record the wound as "Stage II pressure injury" with precise anatomical location (e.g., sacral, heel, ischial) 2
  • Measure and document length, width, and depth in centimeters at this visit and at every subsequent encounter to distinguish true healing from expansion 3, 2
  • Describe the central nodule specifically: measure its diameter (0.5 cm), height above wound bed, color, consistency (firm vs. soft), and whether it is fixed to underlying structures 4
  • Document periwound skin as "pink, intact, without erythema, warmth, or induration" to establish baseline for infection monitoring 3

Critical Atypical Feature Assessment

The raised central nodule is an atypical finding that requires explicit documentation and urgent action. 1 While you state no systemic infection is present, this nodule pattern demands:

  • Immediate consideration of biopsy for any recalcitrant or atypical wound, as lesions appearing to be diabetic foot ulcers may be malignancies 1
  • Document whether the nodule is friable, has abnormal granulation tissue, or exhibits unusual color (these are secondary signs suggesting either infection or malignancy) 1
  • Record the patient's diabetes control (HbA1c 7.2%) and mobility status (ambulating with assistance) as these directly impact healing prognosis 5

Infection Status Documentation

Clinical Signs Assessment

Even without systemic infection, document the presence or absence of all inflammatory signs:

  • Erythema extent: "No erythema beyond wound margins" or measure any present in centimeters 1
  • Warmth: "Periwound temperature equal to surrounding skin" 1
  • Tenderness/pain: Document patient's pain score and whether tenderness is present on palpation 1
  • Induration: "No induration palpable" 1
  • Drainage: "No purulent or non-purulent drainage present" 1, 3

Infection must be diagnosed clinically based on at least 2 classic signs of inflammation or purulent secretions—document explicitly that fewer than 2 signs are present to justify "no infection" classification. 1, 5

Vascular Assessment Documentation

Do not rely solely on clinical examination; up to 50% of diabetic foot ulcer patients have peripheral arterial disease despite palpable pulses. 3

  • Palpate and document dorsalis pedis and posterior tibial pulses bilaterally (present/diminished/absent) 3
  • Record ankle-brachial index (ABI) if available—values <0.9 indicate PAD, <0.6 significant ischemia, <0.5 critical limb ischemia 1, 3
  • Document capillary refill time, skin temperature, and dependent rubor or pallor on elevation 3
  • If ABI >1.3 (calcified vessels common in diabetes), document need for toe-brachial index or duplex ultrasound 3

Neuropathy Assessment

  • Test and document protective sensation using 10-g monofilament at multiple foot sites 3, 5
  • Record whether patient can feel the nodule or wound (loss of sensation present in 78% of diabetic foot ulcers) 3

Wound Bed and Surrounding Tissue

  • Describe wound bed composition: percentage of granulation tissue, slough, necrotic tissue, or exposed deeper structures 3
  • Document whether probe-to-bone test is positive (critical for osteomyelitis assessment in diabetic wounds) 5
  • Record any undermining or tunneling with measurements 1

Pressure Relief Documentation

  • Document current off-loading strategy (e.g., heel protector, pressure-redistributing mattress, repositioning schedule) 1
  • Note patient's mobility limitations (ambulating with assistance) and how this affects pressure relief 3

Recommended Documentation Template

"Stage II pressure injury, [location], measuring [length] × [width] × [depth] cm. Central raised nodule 0.5 cm diameter, [color], [consistency]. Periwound skin pink, intact, without erythema (0 cm), warmth, tenderness, or induration. No purulent or non-purulent drainage. Dorsalis pedis pulse [present/absent], posterior tibial pulse [present/absent]. Capillary refill [time]. 10-g monofilament sensation [intact/absent]. Probe-to-bone test [positive/negative]. Patient ambulating with assistance. HbA1c 7.2%. No systemic signs of infection (afebrile, normal WBC). Atypical central nodule warrants biopsy consideration to exclude malignancy. Plan: [specific interventions]." 1, 3, 4

Critical Next Steps

  • Obtain plain radiographs within 24 hours to evaluate for underlying osteomyelitis given diabetic status 5
  • Consider urgent surgical or dermatology consultation for nodule biopsy given atypical presentation 1
  • Reassess wound measurements weekly and document percentage change to detect healing failure early 3, 2
  • If wound fails to shrink by ≥50% after 4 weeks, reassess perfusion and infection status and escalate care 3

Common Documentation Pitfalls to Avoid

  • Never record "wound improving" without objective measurements—subjective impressions delay recognition of treatment failure 3
  • Do not document "no infection" based solely on absence of purulent drainage—infection requires assessment of all inflammatory signs 1
  • Avoid assuming adequate perfusion from palpable pulses alone in diabetic patients—objective vascular testing is mandatory 3
  • Do not dismiss the atypical nodule as benign granulation tissue without histologic confirmation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Wound-healing protocols for diabetic foot and pressure ulcers.

Surgical technology international, 2003

Guideline

Greyish Discoloration of Foot Wound Borders: Urgent Evaluation and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The importance of wound documentation and classification.

British journal of nursing (Mark Allen Publishing), 1999

Guideline

Diabetic Foot Infection with Likely Osteomyelitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the key components of advanced wound care documentation for an elderly patient with limited mobility and comorbidities such as diabetes, vascular disease, or chronic kidney disease, including wound bed characteristics, wound descriptions, wound tissue types in stages of pressure injuries, and types of tissue debridement?
What is the best dressing for a patient with a bedsore, considering their limited mobility and potential underlying conditions such as diabetes or vascular disease?
What is the best treatment plan for diabetic ulcers on the lower extremities?
What is the management approach for a diabetic patient with cellulitis and a hematoma?
What is the management for an elderly lady with diabetes mellitus (DM), dementia, hypothyroidism, and a seizure disorder who has developed grade 2 and grade 3 pressure sores on her right ankle?
In a patient over 70 years old with dementia, diabetes, and cardiovascular disease who presents with classic bullous pemphigoid, what is the recommended first‑line therapy and appropriate steroid‑sparing second‑line options?
What are the clinical and laboratory differences among viral meningitis, bacterial meningitis, and aseptic meningitis?
What is the recommended management for an otherwise healthy adult with an uncomplicated upper respiratory infection?
What is a safe taper schedule for atomoxetine in a 16‑year‑old patient with autism spectrum disorder, attention‑deficit/hyperactivity disorder, anxiety, insomnia, and tics who is currently taking trazodone for sleep and citalopram 30 mg for anxiety (planned increase)?
What pre‑conception investigations for a male planning pregnancy are covered by the Australian Medicare Benefits Schedule?
When is tigecycline appropriate for treating infections caused by carbapenemase‑producing organisms, and what dosing regimen should be used?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.